Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/16900372

Download in:

View as

General Info

PMID
16900372